Leadership Overview
Organogenesis has 6 executives leading key functions including strategy, operations, marketing, finance, and technology.
Driven by innovation, Organogenesis is dedicated to advancing regenerative medicine, empowering healing across advanced wound care, surgical, and sports medicine markets with a commitment to patient outcomes and market leadership.
Driven by innovation, Organogenesis is dedicated to advancing regenerative medicine, empowering healing across advanced wound care, surgical, and sports medicine markets with a commitment to patient outcomes and market leadership.
Leadership Roles at Organogenesis
Gary Gillheeney - President, Chief Executive Officer and Chair of the Board
Gary Gillheeney, the President, Chief Executive Officer and Chair of the Board at Organogenesis, directs the company's overarching strategy and governance. Gillheeney's leadership guides Organogenesis' mission to empower healing through innovative regenerative medicine solutions. This executive role involves setting the strategic vision for product development, manufacturing, and market penetration in advanced wound care, surgical, and sports medicine sectors. Overseeing board activities, Gillheeney ensures alignment with corporate objectives and long-term value creation. The Chief Executive Officer's responsibilities extend to fostering a culture of innovation and operational excellence, driving the company's growth trajectory and solidifying its market position. Gary Gillheeney's executive oversight is critical for navigating the complexities of the regenerative medicine landscape and achieving sustained success.
Philip Laughlin - Chief Executive Officer & President & Board Member
Philip Laughlin, the Chief Executive Officer & President & Board Member at Organogenesis, executes the strategic direction established for the company. Laughlin's role focuses on driving operational performance and market expansion within the regenerative medicine sector. This executive position involves overseeing all facets of Organogenesis' business, from product innovation to commercialization efforts in advanced wound care and sports medicine. The Chief Executive Officer & President & Board Member ensures that the company's development and manufacturing processes meet the highest standards, supporting the mission to empower healing. Laughlin's leadership is pivotal in cultivating strategic partnerships and enhancing the company's competitive edge. Philip Laughlin's commitment to advancing patient care through cutting-edge regenerative therapies underpins the organization's continued growth and impact.
David Francisco - Chief Financial Officer
David Francisco, the Chief Financial Officer at Organogenesis, directs the company's financial planning, reporting, and capital management. Francisco's financial acumen is essential for supporting Organogenesis' growth and innovation in regenerative medicine. This executive position involves overseeing budgeting, forecasting, investor relations, and ensuring fiscal responsibility across all operations. The Chief Financial Officer plays a key part in strategic decision-making, evaluating investment opportunities and managing financial risks associated with product development and market expansion. Francisco's leadership ensures the financial health of the organization, enabling continued investment in advanced wound care and sports medicine solutions. David Francisco's financial stewardship is critical for sustaining Organogenesis' mission to empower healing and achieve long-term profitability.
Patrick Bilbo - Chief Operating Officer
Patrick Bilbo, the Chief Operating Officer at Organogenesis, manages the company's day-to-day operations and ensures efficient execution of its strategic initiatives. Bilbo's operational leadership is central to Organogenesis' ability to develop, manufacture, and distribute its regenerative medicine products. This role encompasses oversight of manufacturing processes, supply chain management, and quality control, all critical for the advanced wound care and surgical markets. The Chief Operating Officer drives operational excellence, optimizing production workflows to meet market demand and maintain product integrity. Bilbo's focus on streamlining operations supports the company's mission to empower healing through reliable and effective therapeutic solutions. Patrick Bilbo's expertise is vital for scaling production and ensuring consistent product availability across all target sectors.
Michael Sabolinski - Chief Marketing Officer
Michael Sabolinski, the Chief Marketing Officer at Organogenesis, spearheads the company's market strategy and brand development. Sabolinski's leadership drives the commercial success of Organogenesis' regenerative medicine portfolio, focusing on advanced wound care and sports medicine applications. This executive role involves defining go-to-market strategies, managing product launches, and enhancing market penetration. The Chief Marketing Officer oversees all marketing communications, digital presence, and customer engagement initiatives to effectively convey the value of Organogenesis' healing solutions. Sabolinski's efforts are crucial for building brand awareness and establishing Organogenesis as a leader in its field. Michael Sabolinski's strategic marketing vision is instrumental in expanding the company's reach and impact within the healthcare industry.
Michael Catarina - Chief Technology Officer
Michael Catarina, the Chief Technology Officer at Organogenesis, leads the company's technological innovation and infrastructure development. Catarina's role is pivotal in advancing Organogenesis' capabilities in regenerative medicine through cutting-edge research and development. This executive position involves overseeing the technological roadmap, ensuring robust data management, and driving the integration of new technologies into product development and manufacturing processes. The Chief Technology Officer is responsible for maintaining the company's technological edge in the advanced wound care and surgical markets. Catarina's focus on innovation supports Organogenesis' mission to empower healing with state-of-the-art solutions. Michael Catarina's technical expertise is fundamental to the company's ongoing pursuit of scientific advancement and market leadership.
Explore Leadership Teams in Manufacturing
Established in 1957, Arjo is a global supplier of medical devices, services, and solutions that improve quality of life for people with reduced mobility and age-related health challenges. The company is based out of Malmoe, Sweden.
Company Leadership CT
AS
CD
CG
Confluent Applies Materials Science to MedTech Innovation. Confluent's engineered solutions to the most challenging design problems enable our OEM medical device customers to offer life-saving products. Our customers rely on Confluent for materials science and associated manufacturing expertise which is critical to the function and value of their most demanding, high growth products - proprietary expertise which spans processing of high purity Nitinol, ultra-high density knitting of biomedical textiles and precision laser treatment of specialty polymers. Confluent partners with leading OEMs to create a selective product portfolio which includes such complex applications as transcatheter heart valves, neurovascular implants, endovascular stent grafts and advanced smart catheters. With facilities in Fremont and Laguna Niguel, California; Warwick, Rhode Island; Windham, Maine; Austin, Texas; Chattanooga, Tennessee; and San Jose, Costa Rica, Confluent has earned the confidence of the leaders in the medical device community through a proven track record of innovative materials science, engineering and manufacturing.
Company Leadership
JG
EP
ME
Based in Buffalo, NY, Nissha Medical Technologies (NMT) is the medical devices business unit and wholly owned subsidiary of Nissha Co. Ltd.. The company offers services, including Design & Manufacturing, Healthcare Solutions and Custom Labeled Products.
Company Leadership
SD
JC
Established in 1971, Sinclair Dental is a dental supply, dental equipment, digital dentistry, clinic design and repair services company that is located in North Vancouver, BC.
Company Leadership
AN
Frequently Asked Questions Regarding Organogenesis Top Executives and Leadership Team
